Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Trinity Industries
TRN
$2.3B
| $3.32M | ﹤0.01% |
125,442
+9,036
| +8% | +$246K |
|
2527
PUT
Snap
SNAP
$8.96B
| $3.31M | ﹤0.01% |
410,000
| – | – |
|
|
UXIN
2528
Uxin Ltd
UXIN
$260M
| $3.3M | ﹤0.01% |
980,709
+271,453
| +38% | +$811K |
|
2529
HCI Group
HCI
$2.28B
| $3.3M | ﹤0.01% |
17,235
-21,983
| -56% | -$4.14M |
|
2530
Kaiser Aluminum
KALU
$2.99B
| $3.3M | ﹤0.01% |
28,758
+2,968
| +12% | +$282K |
|
|
CRCL
2531
CALL
Circle Internet Group
CRCL
$19.1B
| $3.3M | ﹤0.01% |
41,600
-48,700
| -54% | -$5.03M |
|
2532
Kilroy Realty
KRC
$4.22B
| $3.29M | ﹤0.01% |
88,152
-31,286
| -26% | -$1.28M |
|
|
MRX
2533
Marex Group Limited Ordinary Shares
MRX
$5.2B
| $3.29M | ﹤0.01% |
85,867
+5,875
| +7% | +$200K |
|
2534
Highwoods Properties
HIW
$3.51B
| $3.29M | ﹤0.01% |
127,488
+65,572
| +106% | +$1.85M |
|
|
ELME
2535
Elme Communities
ELME
$144M
| $3.29M | ﹤0.01% |
188,934
-154,338
| -45% | -$2.62M |
|
2536
West Fraser Timber
WFG
$5.5B
| $3.29M | ﹤0.01% |
53,787
-9,378
| -15% | -$587K |
|
2537
Global Industrial
GIC
$1.49B
| $3.29M | ﹤0.01% |
112,482
+10,561
| +10% | +$322K |
|
|
NEE.PRT
2538
NextEra Energy 7.234% Corporate Units
NEE.PRT
$1.47B
| $3.28M | ﹤0.01% |
+67,317
| New | +$3.36M |
|
2539
Accel Entertainment
ACEL
$1B
| $3.28M | ﹤0.01% |
287,258
+33,702
| +13% | +$355K |
|
2540
PUT
Core Scientific
CORZ
$6.36B
| $3.28M | ﹤0.01% |
225,000
-263,900
| -54% | -$4.6M |
|
2541
Center Bancorp
CNOB
$1.81B
| $3.27M | ﹤0.01% |
124,901
+23,720
| +23% | +$601K |
|
2542
Endava
DAVA
$167M
| $3.27M | ﹤0.01% |
517,985
+259,058
| +100% | +$1.98M |
|
|
LIF
2543
Life360
LIF
$4.09B
| $3.27M | ﹤0.01% |
50,936
+27,873
| +121% | +$2.32M |
|
2544
RXO
RXO
$3.85B
| $3.26M | ﹤0.01% |
258,124
-17,372
| -6% | -$256K |
|
2545
Community Trust Bancorp
CTBI
$1.44B
| $3.26M | ﹤0.01% |
57,740
+4,170
| +8% | +$230K |
|
2546
Walker & Dunlop
WD
$1.45B
| $3.26M | ﹤0.01% |
54,236
+7,356
| +16% | +$522K |
|
2547
Tango Therapeutics
TNGX
$4.32B
| $3.26M | ﹤0.01% |
368,187
+2,507
| +0.7% | +$21.6K |
|
2548
National Vision
EYE
$1.54B
| $3.25M | ﹤0.01% |
125,908
+10,995
| +10% | +$296K |
|
2549
Elastic
ESTC
$8.94B
| $3.25M | ﹤0.01% |
43,040
-458,264
| -91% | -$37.4M |
|
2550
SentinelOne
S
$8.17B
| $3.24M | ﹤0.01% |
216,323
+107,507
| +99% | +$1.76M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.